Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
about
Perspectives of nanotechnology in minimally invasive therapy of breast cancerLipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applicationsDiscovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug deliveryLipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.Glutathione modified gold nanorods with excellent biocompatibility and weak protein adsorption, targeting imaging and therapy toward tumor cells.Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.Folic-acid-conjugated pullulan/poly(DL-lactide-co-glycolide) graft copolymer nanoparticles for folate-receptor-mediated drug delivery.Folic acid-targeted disulfide-based cross-linking micelle for enhanced drug encapsulation stability and site-specific drug delivery against tumors.Synthesis, Structural Characterization, and Preclinical Efficacy of a Novel Paclitaxel-Loaded Alginate Nanoparticle for Breast Cancer TreatmentLiposome-like Nanostructures for Drug Delivery.Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancerDevelopment of lipid-shell and polymer core nanoparticles with water-soluble salidroside for anti-cancer therapy.Concepts and practices used to develop functional PLGA-based nanoparticulate systemsLipid-coated polymeric nanoparticles for cancer drug delivery.In vitro evaluation of antisense oligonucleotide functionalized core-shell nanoparticles loaded with α-tocopherol succinate.A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours.Biodegradable polymers for targeted delivery of anti-cancer drugs.Concanavaline A conjugated bacterial polyester-based PHBHHx nanoparticles loaded with curcumin for breast cancer therapy.A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.Oestrone-targeted liposomes for mitoxantrone delivery via oestrogen receptor - synthesis, physicochemical characterization and in-vitro evaluation.Effective method of chitosan-coated alginate nanoparticles for target drug delivery applications.Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin.Development and validation of a reversed-phase HPLC method for the quantification of paclitaxel in different PLGA nanocarriers.Improved Antitumor Efficacy of Hyaluronic Acid-Complexed Paclitaxel Nanoemulsions in Treating Non-Small Cell Lung Cancer.Role of Four Different Kinds of Polyethylenimines (PEIs) in Preparation of Polymeric Lipid Nanoparticles and Their Anticancer Activity Study.Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation.Supramolecular nanofibrils inhibit cancer progression in vitro and in vivoPharmacokinetics and in vivo biodistribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine.Folate-PEG-decorated docetaxel lipid nanoemulsion for improved antitumor activity.Therapeutic efficacy of folate receptor-targeted amphiphilic cyclodextrin nanoparticles as a novel vehicle for paclitaxel delivery in breast cancer.Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system.Preparation of particulate polymeric therapeutics for medical applicationsPreparation and Evaluation of PEGylated and Folate-PEGylated Liposomes Containing Paclitaxel for Lymphatic Delivery
P2860
Q26828806-AADB8543-8BD2-409C-ADE4-8BAB14196859Q28076544-BDFFEBE9-723D-477A-8DEC-D8C5F45C0E4EQ28652407-28025E9F-47B1-41CA-B274-7BDE57C1ABAEQ30366990-95B9932F-6B19-4498-B684-7BE3332C995AQ34802935-BC9643D2-7806-4481-8956-2FC51A80ACDDQ35201534-8BE73057-C595-4288-A853-799BFBBDDCEBQ35264302-6C9AD745-C213-4F09-825C-D9994F5C0F74Q35981477-0E9FAB1C-DD49-4FF6-9DB1-E468B2E5A9CEQ37254024-01D8B3CB-7BFB-4EE2-94AE-AA4516A88384Q37424654-1C7D484F-2E99-47AF-B482-13E3A30D4889Q37603577-011BF1A2-C4C0-4B15-9CE1-5F5ABB82A76AQ37683953-0B97E789-1C90-4CF1-8FE9-6D8D9D602693Q38086377-9229BCCD-C8B0-4B47-9170-1F48A0FCF945Q38556750-05B791B2-6351-4E5F-9DDF-2961786A05FDQ38697575-89A076F6-7E9D-40BA-882F-74BCD77B4CF6Q38733989-96350436-7D7A-4840-8CCE-83242FAD4D2CQ38777436-5D150E70-2B4C-4211-88D4-2EEB00792FC8Q38780375-EE1C9299-9441-4AD4-A97A-DE0C38CB7692Q38818796-D9A70F0D-6A47-4B6F-B7C5-E86947553060Q38818984-607EA674-7378-4D70-B13B-3B4166D33BEFQ38831152-9F1D765A-3212-40D5-83FE-2F06F5CA1D65Q38848191-EA072229-FA2B-4C0A-923F-C25B496BE26CQ38859668-C1A5ADAE-EDC1-4F45-BFA2-520621439D8BQ40951484-78C7168B-8232-41F3-B00A-AB953959510EQ41180575-5559FC98-56A0-4711-9A75-4CD58321BBCBQ41601504-C07B2778-F74D-49BA-9269-D87778F50BB2Q42794295-196E581C-86F4-49D6-B676-7A0E8B1C486FQ45235236-D587125B-E9F8-4109-86E8-F754402F77A0Q49154861-28703550-291A-45FF-BD17-C4534FA71847Q50852560-608E6D30-FE53-42A2-92C7-B98F119F54EDQ55220123-1C5C54D7-3CB9-40A0-BA42-049BFA4B4C74Q57498734-C59CB44F-A5D2-45DD-9FB2-48728A2F8BDBQ59113498-A416334B-9F44-4776-81A3-6678CE460451
P2860
Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@en
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@nl
type
label
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@en
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@nl
prefLabel
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@en
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@nl
P2093
P1476
Paclitaxel loaded folic acid t ...... vitro and in vivo evaluation.
@en
P2093
Haichang Zhang
Hanjie Wang
Huaqing Wang
Jinghua Han
Peiqi Zhao
Ruifang Niu
P304
P356
10.1016/J.EJPB.2012.03.004
P407
P577
2012-03-14T00:00:00Z